GSK2849330,zenocutuzumab,afatinib,seribantumab
boehringer ingelheim,gsk,merus,elevation oncology
['zenocutuzumab', 'seribantumab', 'pancreatic', 'crestone', 'afatinib', 'gsk']
 intersting case on seribantumab in nrg1 fusion pos #pdac anti-her3 igg2, supported by crestone phs-ii: orr 33% dcr 92% ras wt &amp; younger nice pr to seribantumab compassionate use programs are essential for rare 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine